Elligo Health Research Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
328
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$40M
- Investors
-
12
Elligo Health Research General Information
Description
Developer of a clinical research platform designed to revolutionize research by eliminating the barriers that contribute to study delays and budget overruns. The company's platform uses electronic health records to find and identify patients for studies and provides physicians with the personnel, procedures, technology, and infrastructure necessary to conduct the trial in clinics, enabling physicians to conduct efficient and cost-effective trials and gain access to new treatment options.
Contact Information
Website
www.elligohealthresearch.comCorporate Office
- 11612 Bee Cave Road
- Building 1, Suite 150
- Austin, TX 78738
- United States
Corporate Office
- 11612 Bee Cave Road
- Building 1, Suite 150
- Austin, TX 78738
- United States
Elligo Health Research Timeline
Elligo Health Research Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Debt - General | 02-Oct-2023 | $40M | Completed | Generating Revenue | ||
6. Later Stage VC (Series E) | 23-Sep-2021 | Completed | Generating Revenue | |||
5. Later Stage VC | 01-Nov-2020 | Completed | Generating Revenue | |||
4. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | 07-May-2019 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 20-Mar-2018 | $16M | $21M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 23-May-2017 | $5M | $5M | Completed | Generating Revenue |
Elligo Health Research Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E-2 | ||||||||
Series E-1 | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 28,082,010 | $0.000100 | 8% | $0.55 | $0.55 | 1x | $0.55 | 14.93% |
Series A | 11,444,587 | $0.000100 | 8% | $0.47 | $0.47 | 1x | $0.47 | 5.77% |
Elligo Health Research Comparisons
Industry
Financing
Details
Elligo Health Research Competitors (47)
One of Elligo Health Research’s 47 competitors is Science 37, a Formerly VC-backed company based in Culver City, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Science 37 | Formerly VC-backed | Culver City, CA | ||||
Curai Health | Venture Capital-Backed | San Francisco, CA | ||||
HealthJoy | Venture Capital-Backed | Chicago, IL | ||||
Streamline Healthcare Solutions | Private Equity-Backed | Oak Brook, IL | ||||
Deep 6 AI | Venture Capital-Backed | Pasadena, CA |
Elligo Health Research Patents
Elligo Health Research Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170039325-A1 | Community referral cluster technology platform | Inactive | 23-Jul-2015 | ||
US-10366780-B2 | Predictive patient to medical treatment matching system and method | Inactive | 24-Jan-2014 | ||
US-20150213234-A1 | Predictive patient to medical treatment matching system and method | Active | 24-Jan-2014 | G16H10/20 |
Elligo Health Research Signals
Elligo Health Research Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Ally Bridge Group | PE/Buyout | Minority | ||
Morgan Stanley Expansion Capital | Growth/Expansion | Minority | ||
Norwest Venture Partners | Venture Capital | Minority | ||
Syneos Health | PE-Backed Company | Minority | ||
121G | Venture Capital | Minority |
Elligo Health Research Acquisitions (4)
Elligo Health Research’s most recent deal was a Merger/Acquisition with BTC of New Bedford. The deal was made on 24-Sep-2021.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
BTC of New Bedford | 24-Sep-2021 | Merger/Acquisition | Other Healthcare Services | ||
ClinEdge | 22-Sep-2021 | Merger/Acquisition | Practice Management (Healthcare) | ||
Root Health | 08-Jun-2021 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
ePatientFinder | 24-May-2018 | Merger/Acquisition | Other Healthcare Technology Systems |
Elligo Health Research Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
BTC of New Bedford | Other Healthcare Services | New Bedford, MA |
Elligo Health Research FAQs
-
When was Elligo Health Research founded?
Elligo Health Research was founded in 2016.
-
Where is Elligo Health Research headquartered?
Elligo Health Research is headquartered in Austin, TX.
-
What is the size of Elligo Health Research?
Elligo Health Research has 328 total employees.
-
What industry is Elligo Health Research in?
Elligo Health Research’s primary industry is Medical Records Systems.
-
Is Elligo Health Research a private or public company?
Elligo Health Research is a Private company.
-
What is Elligo Health Research’s current revenue?
The current revenue for Elligo Health Research is
. -
How much funding has Elligo Health Research raised over time?
Elligo Health Research has raised $253M.
-
Who are Elligo Health Research’s investors?
Ally Bridge Group, Morgan Stanley Expansion Capital, Norwest Venture Partners, Syneos Health, and 121G are 5 of 12 investors who have invested in Elligo Health Research.
-
Who are Elligo Health Research’s competitors?
Science 37, Curai Health, HealthJoy, Streamline Healthcare Solutions, and Deep 6 AI are some of the 47 competitors of Elligo Health Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »